NuVasive Inc. has received FDA 510(k) clearance for its portfolio of static and expandable thoracolumbar interbody implants for the treatment of sagittal malalignment and deformities of the spine, according to a press release.

Ten years ago, researchers at NCI reported use of CD19-directed chimeric antigen receptor T-cell therapy that successfully induced remission in a patient with follicular lymphoma.

In this Healio Video Perspective from the virtual AAO annual meeting, Cathleen M. McCabe, MD, discusses study data for the AcrySof IQ Vivity lens (Alcon), a nondiffractive presbyopia-correcting IOL.

The FDA granted fast track designation to several agents under investigation for the treatment of patients with certain solid tumors or hematologic malignancies.

Palliative care is an important piece of cancer care that improves the quality of life for patients with cancer.

On Oct. 25, 2016, HemOnc Today published an editorial titled “Animal Farm, 1984 and The Hunger Games,” which warned members of the electorate to be thoughtful about their imminent decisions and predicted a time of dystopia, contingent on the outcome.

I agree that there is a need for enforcement and compliance, which historically has not happened. However, I don’t think rigid enforcement ultimately helps patients.

The goal of most clinical trials — including those that test a medication, assess a diagnostic device or evaluate a surgical technique — is to gather and share information about the efficacy and safety of an intervention.

Late-life air pollution exposure among women aged 80 years or older appeared associated with increased risk for depressive episodes and episodic memory declines, according to study results published in Journal of the American Geriatrics Society.

In this video, Ryan W. Jacobs, MD, discussed next-generation treatments for novel targets and other developments on the horizon for chronic lymphocytic leukemia, including perfecting CAR T-cell therapy.